Literature DB >> 7562471

Efflux of intracellular colchicine in lymphocytes with colchicine-specific Fab fragments.

O N Chappey1, E Niel, M Debray, J L Wautier, J M Scherrmann.   

Abstract

Uptake of [3H]colchicine (2.5 ng/ml) by human lymphocytes in culture was slow in the length of time to reach steady state (> 48 hr) and was limited in the maximal intracellular colchicine amount (1-2% of total extracellular colchicine). Efflux of intracellular colchicine was investigated 40 hr after colchicine cell exposure by using either washing of the extracellular medium or adding different colchicine-specific Fab fragments:colchicine dose molar ratios of 0.5, 1 and 5. Except for the 0.5 dose molar ratio, the kinetics of [3H]colchicine efflux from lymphocytes induced by extracellular specific Fab fragments were similar to those obtained by washing and were characterized by a first-order decline with half-lives ranging from 15.5 to 16.4 hr. These half-lives were in the same range as those characterizing the dissociation of colchicine from the intracellular tubulin receptor. Our data demonstrate that a tightly bound intracellular toxin may be extracted by antibody with high affinity for the toxin present in the extracellular space at a rate depending on the rate of dissociation of the toxin from its receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562471

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  2 in total

1.  P-glycoprotein is more efficient at limiting uptake than inducing efflux of colchicine and vinblastine in HL-60 cells.

Authors:  X Declèves; O Chappey; B Boval; E Niel; J M Scherrmann
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

2.  Design of cocaethylene and cocaine conjugates to produce highly selective polyclonal antibodies.

Authors:  Caroline Gadjou; Yannic Danger; Pierre Sandouk; Jean-Michel Scherrmann; Dominique Blanchard; Gilles Folléa; Hervé Galons
Journal:  Int J Biomed Sci       Date:  2006-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.